See a breakdown of Audience & Reach for Adjuvant Docetaxel for Intermediate or High Risk Prostate Cancer After Radiation: Highlights in GU Oncology from ASCO 2018 (BMIC-060)
See Brand Safety for Adjuvant Docetaxel for Intermediate or High Risk Prostate Cancer After Radiation: Highlights in GU Oncology from ASCO 2018 (BMIC-060)
How much does it cost to advertise on The Beacon (Audio)?
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More